Toward the development of α1a adrenergic receptor antagonists

被引：36
作者：
Bock, MG [1 ]
Patane, MA [1 ]
机构：
[1] Merck Res Labs, West Point, PA 19486 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35 | 2000年 / 35卷
关键词：
D O I：
10.1016/S0065-7743(00)35021-7
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：221 / 230
页数：10
相关论文
共 84 条
  • [1] Adkison K K, 1998, Pharm Biotechnol, V11, P423
  • [2] Akiyama K., 1997, Neurourology and Urodynamics, V16, P492
  • [3] Akiyama K, 1999, J PHARMACOL EXP THER, V291, P81
  • [4] The concept of uroselectivity
    Andersson, KE
    [J]. EUROPEAN UROLOGY, 1998, 33 : 7 - 11
  • [5] Blue D. R. Jr., 1996, Neurourology and Urodynamics, V15, P345
  • [6] Blue David R. Jr., 1997, Journal of Urology, V157, P190
  • [7] Blue DR, 1997, BRIT J PHARMACOL, V120, pP107
  • [8] (+)-NIGULDIPINE BINDS WITH VERY HIGH-AFFINITY TO CA-2+ CHANNELS AND TO A SUBTYPE OF ALPHA-1-ADRENOCEPTORS
    BOER, R
    GRASSEGGER, A
    SCHUDT, C
    GLOSSMANN, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1989, 172 (02): : 131 - 145
  • [9] ALPHA-ADRENERGIC BLOCKERS IN PROSTATISM
    BOREHAM, PF
    BRAITHWAITE, P
    MILEWSKI, P
    PEARSON, H
    [J]. BRITISH JOURNAL OF SURGERY, 1977, 64 (10) : 756 - 757
  • [10] Brawer M K, 1993, Arch Fam Med, V2, P929, DOI 10.1001/archfami.2.9.929
123456789